Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Immune Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 12.2M | Jul 25, 2022 | By trust | ||
Immune Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 20 | Jul 25, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMUN | Immune Therapeutics, Inc. | Jul 25, 2022 | 0 | $0 | 3 | Dec 15, 2022 | Director, 10%+ Owner |